Stock Report

Download full stock data and analysis for free Last Updated: 07-May-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Remus Pharmaceuticals Ltd

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: REMUS

₹746.90

up-down-arrow ₹31.50 (4.40%)

As on 07-May-2026IST

Market cap

info icon

₹880 Cr

Revenue (TTM)

info icon

₹620 Cr

P/E Ratio

info icon

30.3

P/B Ratio

info icon

3.4

Div. Yield

info icon

0.1 %

REMUS Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio
NSE
NSE

Stock Range

Today’s Range

Low: 725.00 High: 749.90

52 Week Range

Low: 580.00 High: 1,139.50

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹38 Cr

  • ROEROE information

    18.6 %

  • ROCEROCE information

    21.9 %

  • Industry P/EIndustry P/E information

    43.3

  • EV/EBITDAEV/EBITDA information

    17.6

  • Debt to EquityDebt to Equity information

    0.1

  • Book ValueBook Value information

    ₹217.2

  • EPSEPS information

    ₹24.7

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    11,784,000

6 Years Aggregate

CFO

₹22.82 Cr

EBITDA

₹90.49 Cr

Net Profit

₹76.47 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
REMUS
6.4 21.2 13.7 -20.9 -- -- --
BSE Healthcare
6.8 11.7 10.6 10.4 26.1 14.0 11.7
As on 07-May-2026
Company
2025
2024
REMUS
-43.5 33.7
BSE Small Cap
-6.6 29.0
BSE Healthcare
-3.3 43.1

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in (₹ Cr)

Annual

*All values are in (₹ Cr)

Annual

*All values are in (₹ Cr)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
 Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
REMUS
746.9 880.2 620.4 38.4 -- 18.6 30.3 3.4
Acutaas Chemicals
2,725.7 22,282.9 1,339.4 356.4 33.2 23.2 62.5 13.5
Cohance Lifesciences
484.9 18,550.7 2,051.5 180.5 11.6 7.7 92 4.9
Granules India
743.5 18,420.0 5,365.6 595.0 16.6 13.3 31 3.6
Natco Pharma
1,155.2 20,672.9 4,560.2 1,544.6 35.1 19.2 13.3 2.4
Onesource Specialty Pharma
1,815.9 20,825.4 1,419.3 20.1 8.4 0.5 1036 3.6
Piramal Pharma
183.7 24,438.2 8,869.1 -383.1 1.0 -4.2 -- 3.0
Rubicon Research
951.4 15,715.1 1,284.3 134.4 -- 30.7 117 12.9
Syngene Intl
467.4 18,948.2 3,738.7 316.7 12.5 7.5 59.8 3.9
Wockhardt
1,637.5 26,595.9 3,373.0 199.0 12.6 5.9 124.9 5.4

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About REMUS

Manufacture of pharmaceuticals, medicinal chemical and botanical products

  • Incorporated

    2015

  • Chairman

    Swapnil Jatinbhai Shah

  • Managing Director

    Arpit Deepakkumar Shah

  • Headquarters

    Ahmedabad, Gujarat

  • Website

    www.remuspharma.com

Looking for more details about Remus Pharmaceuticals Ltd’s IPO? Explore our IPO Details page.

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

Announcements

View Announcements

No News & Announcements are available.

FAQs for REMUS

The share price of Remus Pharmaceuticals Ltd is ₹746.90 (NSE) as of 07-May-2026 IST. Remus Pharmaceuticals Ltd has given a return of -20.94% in the last 1 years.

The P/E ratio of Remus Pharmaceuticals Ltd is 30.28 times as on 07-May-2026, a 30 discount to its peers’ median range of 43.30 times.
The P/B ratio of Remus Pharmaceuticals Ltd is 3.36 times as on 07-May-2026, a 6 discount to its peers’ median range of 3.59 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
22.68
5.15
2024
6.18
6.43
2023
0.00
0.00
2022
0.00
0.00
2021
0.00
0.00

The 52-week high and low of Remus Pharmaceuticals Ltd are Rs 1,139.50 and Rs 580.00 as of 07-May-2026.

Remus Pharmaceuticals Ltd has a market capitalisation of ₹ 880 Cr as on 07-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Remus Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.